Today's Veterinary Business

DEC 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link:

Contents of this Issue


Page 19 of 69

PROZINC is a registered trademark of Boehringer Ingelheim Vetmedica, Inc. © 2017 Boehringer Ingelheim Vetmedica, Inc. PET-0287-PROZ0517 17425 Confi dence Because of its effi cacy proven to improve clinical signs 1 and a duration of action appropriate for felines, 2,3 I believe PROZINC is the ideal insulin choice for newly diagnosed feline diabetic patients. Invitation (neutral) Let's take a look at why PROZINC is different… Acknowledge the customer as the decision-maker: …so you can decide whether PROZINC is the right insulin choice to meet your patients' individual needs. First, always ask if a Boehringer Ingelheim representative has visited the practice recently: Doctor, have you been intr the ideal insulin solution for all newly diagnosed cats? If YES, confi rm the benefi ts! If NO, detail as the primary contact. CHECK-OFF & ECHO NOTES OZINC is focused on putting diabetic cats first. Boehringer Ingelheim provides unmatched product support, technical assistance, and resources to help your customers and their clients manage feline diabetes. Boehringer Ingelheim o ers clinics: Feline-specifi c educational resources, including the PROZINC website (, which provide reliable and easy-to-access information for you and your customers' healthcare team Pet owner education materials and tools that deliver valuable information to your customers' clients Technical support from Field Service Veterinarians and our on-call support team (1-866-638-2226) that provides assistance when it's needed I believe that we should be starting newly diagnosed cats on PROZINC. I think it gives them the best chance of eliminating clinical signs in a safe and healthy way. — Richard E. Goldstein, DVM, DACVIM, DECVIM-CA Chief Medical O cer, The Animal Medical Center in New York City PROZINC is focused on your customers and their patients. References: 1. Nelson RW, Henley K, Cole C, et al. Field safety and e cacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats. J Vet Intern Med. 2009;23:787–793. 2. Rucinsky R, Cook A, Haley S, et al. AAHA diabetes management guidelines for dogs and cats. J Am Anim Hosp Assoc. 2010;46(3):215–224. 3. Nelson RW. Disorders of the endocrine pancreas. In: Nelson RW, Cuoto CG, eds. Essentials of Small Animal Internal Medicine. 4th ed. St. Louis, MO: Mosby Elsevier; 2008:764–802. 4. Borin-Crivellenti S, Bonagura JD, Gilor C. Comparison of precision and accuracy of U100 and U40 insulin syringes. 2014 ACVIM Forum Research Abstracts Program. J Vet Intern Med. 2014;28:1029.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - DEC 2018